Wallander M, et al. - Authors gauged how androgen deprivation therapy (ADT) in patients with prostate cancer is linked to risk of incident fractures and non-skeletal fall injuries, compared to both those not taking ADT and patients without prostate cancer. Participants were 159,662 men without prostate cancer, 6,954 with prostate cancer and current ADT and 13,128 men with prostate cancer without ADT. Compared to both patients without prostate cancer and compared to those with prostate cancer without ADT, the patients with prostate cancer and ADT have a substantially increased risk of osteoporotic fractures, but not of non-skeletal fall injury.